|
|
|
40
|
A774R
|
QUETIDIN XR 300MG TAB (ABB/PHA) QUETIAPINE XR
|
QUETIAPINE XR
|
QUETIDIN XR
|
30'S
|
BP
|
80.44
|
2.68
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A774R
|
QUETIDIN XR 300MG TAB (ABB/PHA) QUETIAPINE XR (BP)
|
QUETIAPINE XR
|
QUETIDIN XR
|
30'S
|
BP
|
80.44
|
2.6813
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
2023-03-07
|
|
|
|
40
|
A774S
|
QUETIAPINE XR 300MG TAB (MCP/AHI)
|
QUETIAPINE XR
|
QUETIAPINE XR
|
3X10
|
BP
|
11.93
|
0.40
|
TABLET
|
0
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A774U
|
QUETIDIN 300MG TAB (ABB/PHA) QUETIAPINE
|
QUETIAPINE
|
QUETIDIN
|
30'S
|
BP
|
35.66
|
1.19
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A774U
|
QUETIDIN 300MG TAB (ABB/PHA) QUETIAPINE (BP)
|
QUETIAPINE
|
QUETIDIN
|
30'S
|
BP
|
35.66
|
1.1887
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
2023-03-07
|
|
|
|
40
|
A774W
|
QUETIAPINE 300MG TAB (MCP/AHI)
|
QUETIAPINE
|
QUETIAPINE
|
3X10
|
BP
|
7.77
|
0.26
|
TABLET
|
0
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A774X
|
APO-QUETIAPINE 300MG TAB (APO) (BP)
|
QUETIAPINE
|
APO-QUETIAPINE
|
100'S
|
BP
|
45.75
|
0.4575
|
TAB
|
84
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
40
|
A7757
|
QUETIDIN XR 50MG TAB (ABB/PHA) QUETIAPINE XR
|
QUETIAPINE XR
|
QUETIDIN XR
|
30'S
|
BP
|
47.22
|
1.57
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A7757
|
QUETIDIN XR 50MG TAB (ABB/PHA) QUETIAPINE XR (BP)
|
QUETIAPINE XR
|
QUETIDIN XR
|
30'S
|
BP
|
47.22
|
1.574
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
2023-03-07
|
|
|
|
40
|
A7758
|
SEROQUEL XR 50MG TAB (AZN/COL) QUETIAPINE XR
|
QUETIAPINE XR
|
SEROQUEL XR
|
30'S
|
C
|
52.74
|
1.76
|
TABLET
|
0
|
TAB
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-05-17
|
2024-03-31
|
Add to Contract as Cat C
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-05-17
|
|
|
|
41
|
A7758
|
SEROQUEL 50MG XR TAB (AZN) QUETIAPINE XR
|
QUETIAPINE XR
|
SEROQUEL
|
30'S
|
BP
|
52.74
|
1.7578
|
TABXR
|
0
|
BOX
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
40
|
A7759
|
QUETIAPINE 50MG TAB (MCP/AHI)
|
QUETIAPINE
|
QUETIAPINE
|
3X10
|
BP
|
2.80
|
0.09
|
TABLET
|
0
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A775A
|
QUETIAPINE XR 50MG TAB (MCP/AHI)
|
QUETIAPINE XR
|
QUETIAPINE XR
|
3X10
|
BP
|
5.65
|
0.19
|
TABLET
|
0
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A7764
|
SQURO SR 400MG TAB (INP/AAL) QUETIAPINE XR
|
QUETIAPINE XR
|
SQURO SR
|
60'S
|
BP
|
163.10
|
2.72
|
TABLET
|
120
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A7766
|
QUETIAPINE 400MG ER TAB (INP)
|
QUETIAPINE XR
|
QUETIAPINE
|
60'S
|
BP
|
27.4007
|
0.4567
|
TABER
|
84
|
BOTT
|
INP
|
INTAS PHARMACEUTICALS LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
40
|
A7811
|
FEMARA 2.5MG TAB (NVS/COL) LETROZOLE
|
LETROZOLE
|
FEMARA
|
30'S
|
C
|
312.61
|
10.42
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
A7811
|
FEMARA 2.5MG TAB (NVS) LETROZOLE (C)
|
LETROZOLE
|
FEMARA
|
30'S
|
C
|
271.83
|
9.0611
|
TAB
|
30
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
A7815
|
LETROL 2.5MG TAB (INP) LETROZOLE
|
LETROZOLE
|
LETROL
|
30'S
|
A
|
7.23
|
0.241
|
TAB
|
30
|
BOX
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
A7818
|
APO-LETROZOLE 2.5MG TAB (APO/COL)
|
LETROZOLE
|
APO-LETROZOLE
|
30'S
|
A
|
7.37
|
0.25
|
TABLET
|
30
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
A781J
|
LETROZOLE 2.5MG TAB (KWA/ATB)
|
LETROZOLE
|
LETROZOLE
|
30'S
|
A
|
8.86
|
0.30
|
TABLET
|
30
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|